Clonality and molecular pathogenesis of mastocytosis

被引:42
作者
Akin, C [1 ]
机构
[1] Univ Michigan, Dept Internal Med, Div Allergy & Immunol, Ann Arbor, MI 48109 USA
关键词
c-kit; mastocytosis; clonality; mutations; mast cells;
D O I
10.1159/000085563
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mast cell is a hematopoietic lineage dependent on Kit signaling for growth, differentiation, and survival. Mast cells are found in excessive numbers in tissues in a heterogeneous group of disorders collectively known as mastocytosis. Last decade has witnessed important advancements in our understanding of the molecular pathology of mastocytosis. First, systemic mastocytosis has been found to be associated with activating codon 816 mutations of the c-kit gene. Second, this mutation was used as a tracking marker to elucidate the clonal nature of mastocytosis. These findings have resulted in consideration of systemic mastocytosis as a clonal neoplastic disorder of a hematopoietic progenitor cell. Improved knowledge of the mechanisms causing pathological mast cell growth will lead to the discovery of novel treatment options including drugs targeting the mutated Kit protein. Copyright (c) 2005 S. Karger AG, Basel
引用
收藏
页码:61 / 69
页数:9
相关论文
共 79 条
  • [1] Multilineage involvement and erythropoietin-"independent" erythroid progenitor cells in a patient with systemic mastocytosis
    Afonja, O
    Amorosi, E
    Ashman, L
    Takeshita, K
    [J]. ANNALS OF HEMATOLOGY, 1998, 77 (04) : 183 - 186
  • [2] A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib
    Akin, C
    Fumo, G
    Yavuz, AS
    Lipsky, PE
    Neckers, L
    Metcalfe, DD
    [J]. BLOOD, 2004, 103 (08) : 3222 - 3225
  • [3] Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis
    Akin, C
    Kirshenbaum, AS
    Semere, T
    Worobec, AS
    Scott, LM
    Metcalfe, DD
    [J]. EXPERIMENTAL HEMATOLOGY, 2000, 28 (02) : 140 - 147
  • [4] The biology of Kit in disease and the application of pharmacogenetics
    Akin, C
    Metcalfe, DD
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (01) : 13 - 19
  • [5] Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit
    Akin, C
    Brockow, K
    D'Ambrosio, C
    Kirshenbaum, AS
    Ma, YS
    Longley, BJ
    Metcalfe, DD
    [J]. EXPERIMENTAL HEMATOLOGY, 2003, 31 (08) : 686 - 692
  • [6] An immunohistochemical study of the bone marrow lesions of systemic mastocytosis - Expression of stem cell factor by lesional mast cells
    Akin, C
    Jaffe, ES
    Raffeld, M
    Kirshenbaum, AS
    Daley, T
    Noel, P
    Metcalfe, DD
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (02) : 242 - 247
  • [7] Baldus SE, 2004, HAEMATOLOGICA, V89, P1525
  • [8] C-kit mutations in core binding factor leukemias
    Beghini, A
    Peterlongo, P
    Ripamonti, CB
    Larizza, L
    Cairoli, R
    Morra, E
    Mecucci, C
    [J]. BLOOD, 2000, 95 (02) : 726 - 727
  • [9] Beghini A, 2001, CANCER, V92, P657, DOI 10.1002/1097-0142(20010801)92:3<657::AID-CNCR1367>3.0.CO
  • [10] 2-D